Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

GLOFITAMAB for B-cell lymphoma: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 95 adverse event reports in the FDA FAERS database where GLOFITAMAB was used for B-cell lymphoma.

Most Reported Side Effects for GLOFITAMAB

Side Effect Reports % Deaths Hosp.
Cytokine release syndrome 415 37.2% 102 239
Disease progression 183 16.4% 78 39
Off label use 129 11.6% 37 44
Death 125 11.2% 125 12
Neutropenia 109 9.8% 18 59
Pyrexia 78 7.0% 15 46
Febrile neutropenia 69 6.2% 2 55
Covid-19 62 5.6% 11 31
Drug ineffective 53 4.8% 10 10
Immune effector cell-associated neurotoxicity syndrome 45 4.0% 17 16
Infection 44 3.9% 28 12
Pneumonia 41 3.7% 11 20
Sepsis 29 2.6% 15 14
Septic shock 27 2.4% 20 15
Alanine aminotransferase increased 26 2.3% 2 15

Other Indications for GLOFITAMAB

Diffuse large b-cell lymphoma (535) Product used for unknown indication (107) Mantle cell lymphoma (60) Diffuse large b-cell lymphoma refractory (55) Non-hodgkin's lymphoma (44) Diffuse large b-cell lymphoma stage iv (38) Follicular lymphoma (29) B-cell lymphoma refractory (27) Richter's syndrome (24) Lymphoma transformation (19)

Other Drugs Used for B-cell lymphoma

RITUXIMAB (7,811) CYCLOPHOSPHAMIDE (4,766) VINCRISTINE (4,346) DOXORUBICIN (3,947) LENALIDOMIDE (3,474) PREDNISONE (2,561) BENDAMUSTINE (1,668) PREDNISOLONE (1,489) ETOPOSIDE (1,268) IDELALISIB (1,240)

Related Pages

GLOFITAMAB Full Profile All B-cell lymphoma Drugs GLOFITAMAB Demographics GLOFITAMAB Timeline